Clinical Trial Update: Study of DM5167 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates DM5167 in patients with advanced breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DM5167

Snippet

Sponsor: DIGMBIO | Conditions: Advanced Breast Cancer | Phase 1 | Status: RECRUITING